CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Standard Biotools Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Standard Biotools Inc
50 MILK STREET, 10TH FLOOR
Phone: (302) 658-7581p:302 658-7581 BOSTON, MA  02109  United States Ticker: LABLAB

Business Summary
Standard BioTools Inc. has a portfolio of technologies that help biomedical researchers develop medicines faster. The Company develops, manufactures, and sells a diversified range of instrumentation, consumables, and services. The Company offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research. Its proprietary multi-omics tools provide unique insights into human health, immune response, and disease states across a broad range of applications, including proteomics and genomics, and other areas of translational and clinical research. The Company's solutions are designed to unlock complex biological information across plasma, single-cell, and spatial proteomics, as well as genomic analyses, enabling researchers to explore disease mechanisms with unprecedented depth and precision. Its advanced platforms are CyTOF and Hyperion.
(Source: 6-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202612/31/2025YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board ThomasCarey 64 1/5/2024 1/5/2024
President, Chief Executive Officer, Director MichaelEgholm 63 4/4/2022 4/4/2022
Chief Financial Officer Hanjoon A.Kim 55 11/11/2024 4/4/2022
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Standard BioTools Singapore Pte. Ltd. Techplace II. Block 5008, #08-08 Singapore Singapore
DVS Sciences, Inc. 639 N. Pastoria Ave Sunnyvale CA United States
Standard BioTools Canada Inc. 1380 Rodick Road Markham ON Canada

Business Names
Business Name
DVS Sciences, Inc.
FLDM
Fluidigm (Shanghai) Instrument Technology Company Limited
25 additional Business Names available in full report.

General Information
Number of Employees: 385 (As of 12/31/2025)
Outstanding Shares: 394,790,441 (As of 11/1/2026)
Shareholders: 227
Stock Exchange: NASD
Federal Tax Id: 770513190
Fax Number: (302) 655-5049


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, November 8, 2026